BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,254,390 | +156.9% | 6,532,000 | +107.2% | 0.00% | – |
| Q2 2023 | $2,434,920 | +5.0% | 3,152,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2,319,872 | +0.8% | 3,152,000 | -40.4% | 0.00% | – |
| Q4 2022 | $2,301,679 | -23.4% | 5,290,000 | 0.0% | 0.00% | – |
| Q3 2022 | $3,003,000 | -30.8% | 5,290,000 | -36.2% | 0.00% | -100.0% |
| Q2 2022 | $4,340,000 | +18.5% | 8,290,000 | +33.9% | 0.00% | – |
| Q1 2022 | $3,663,000 | -32.4% | 6,190,000 | -19.5% | 0.00% | -100.0% |
| Q4 2021 | $5,421,000 | +285.8% | 7,690,000 | +653.2% | 0.00% | – |
| Q3 2021 | $1,405,000 | -57.0% | 1,021,000 | -49.0% | 0.00% | – |
| Q2 2021 | $3,268,000 | -40.0% | 2,000,000 | -39.1% | 0.00% | -100.0% |
| Q1 2021 | $5,448,000 | – | 3,283,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |